Cargando…
All‐cause mortality versus cancer‐specific mortality as outcome in cancer screening trials: A review and modeling study
BACKGROUND: All‐cause mortality has been suggested as an end‐point in cancer screening trials in order to avoid biases in attributing the cause of death. The aim of this study was to investigate which sample size and follow‐up is needed to find a significant reduction in all‐cause mortality. METHODS...
Autores principales: | Heijnsdijk, Eveline A. M., Csanádi, Marcell, Gini, Andrea, ten Haaf, Kevin, Bendes, Rita, Anttila, Ahti, Senore, Carlo, de Koning, Harry J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6792501/ https://www.ncbi.nlm.nih.gov/pubmed/31422585 http://dx.doi.org/10.1002/cam4.2476 |
Ejemplares similares
-
Cost‐effectiveness of multiparametric magnetic resonance imaging and MRI‐guided biopsy in a population‐based prostate cancer screening setting using a micro‐simulation model
por: Getaneh, Abraham M., et al.
Publicado: (2021) -
Screening for cancers with a good prognosis: The case of testicular germ cell cancer
por: Heijnsdijk, Eveline A. M., et al.
Publicado: (2021) -
Assessment of harms, benefits, and cost‐effectiveness of prostate cancer screening: A micro‐simulation study of 230 scenarios
por: Getaneh, Abraham M., et al.
Publicado: (2020) -
Overcoming barriers: Modelling the effect of potential future changes of organized breast cancer screening in Italy
por: Zielonke, Nadine, et al.
Publicado: (2023) -
The EU-TOPIA evaluation tool: An online modelling-based tool for informing breast, cervical, and colorectal cancer screening decisions in Europe
por: Gini, Andrea, et al.
Publicado: (2021)